MyFinsight
Home
About
Contact
Back
Income Statement
Coherus Oncology, Inc. (CHRS)
source: myfinsight.com
Download
Download image
Net income from
discontinued operations, net...
$342,629K
Net income (loss)
$297,767K
(2404.52%↑ Y/Y)
Net loss from
continuing operations
-$44,862K
Loss from continuing
operations before income...
-$44,862K
(-247.20%↓ Y/Y)
Other income
(expense), net
$2,901K
(97.75%↑ Y/Y)
Revenue from contract
with customer,...
$9,959K
Revenue from contract
with customer,...
$295K
Interest expense
$2,277K
(-57.31%↓ Y/Y)
Loss from operations
-$45,486K
(-121.79%↓ Y/Y)
Net revenue
$10,254K
(-84.22%↓ Y/Y)
Total costs and
expenses
$55,740K
(-34.80%↓ Y/Y)
Cost of goods sold
$3,395K
(-88.03%↓ Y/Y)
Research and development
$26,306K
(19.82%↑ Y/Y)
Selling, general and
administrative
$26,039K
(-25.95%↓ Y/Y)
Back